thats just marketing fluff. the results speak for themselves. Lower respiratory tract disease, asthma/reactive airway disease (for children over 2 years of age) and primary upper respiratory tract disease are okay but not the game changer here.
Pneumonia was the big one. Its back to the drawing board.
87%PPA, 85%NPA for Pneumonia in Australian tests, but with a bigger sample 63%PPA and 62%NPA. That discrepancy is the issue.
- Forums
- ASX - By Stock
- RAP
- Ann: Positive Preliminary Results from SMARTCOUGH-C-2 Study
Ann: Positive Preliminary Results from SMARTCOUGH-C-2 Study, page-45
-
- There are more pages in this discussion • 325 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)